https://orcid.org/0000-0001-6947-6099
Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qian He, Shuying Liu, Zhenglun Liang, Shan Lu, Wei Cun & Qunying Mao. (2023) Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses. Emerging Microbes & Infections 12:1.
Read now
Read now
Xuesong He & Xiao Xue Zeng. (2022) Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?. Drug Design, Development and Therapy 16, pages 951-972.
Read now
Read now
Articles from other publishers (104)
Constant Gillot, Jean-Louis Bayart, Mélanie Closset, Julien Cabo, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils & Julien Favresse. (2023) Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing. Clinical Chemistry and Laboratory Medicine (CCLM) 61:9, pages 1670-1675.
Crossref
Crossref
Julien Favresse, Jonathan Douxfils, Brandon Henry, Giuseppe Lippi & Mario Plebani. (2023)
Clinical Chemistry and Laboratory Medicine
celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2
. Clinical Chemistry and Laboratory Medicine (CCLM) 61:5, pages 811-821.
Crossref
Crossref
Maria Elena Romero-Ibarguengoitia, Diego Rivera-Salinas, Riccardo Sarti, Riccardo Levi, Maximiliano Mollura, Arnulfo Garza-Silva, Andrea Rivera-Cavazos, Yodira Guadalupe Hernández-Ruíz, Irene Antonieta Barco-Flores, Arnulfo González-Cantú, Miguel Ángel Sanz-Sánchez, Milton Henriques Guimarães Júnior, Chiara Pozzi, Riccardo Barbieri, Devany Paola Morales-Rodriguez, Mauro Martins Texeira & Maria Rescigno. (2023) Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico. Vaccines 11:4, pages 842.
Crossref
Crossref
Koichi Kamei, Masao Ogura, Mai Sato, Kentaro Nishi, Kensuke Shoji, Takanori Funaki, Chikara Ogimi & Shuichi Ito. (2022) Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents. Pediatric Nephrology 38:4, pages 1099-1106.
Crossref
Crossref
Eleonora Sabetta, Maddalena Noviello, Clara Sciorati, Marco Viganò, Rebecca De Lorenzo, Valeria Beretta, Veronica Valtolina, Chiara Di Resta, Giuseppe Banfi, Davide Ferrari, Massimo Locatelli, Fabio Ciceri, Chiara Bonini, Patrizia Rovere-Querini & Rossella Tomaiuolo. (2023) A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies. Frontiers in Immunology 14.
Crossref
Crossref
Yoshifumi Uwamino, Kengo Nagashima, Ayumi Yoshifuji, Shigeru Suga, Mizuho Nagao, Takao Fujisawa, Munekazu Ryuzaki, Yoshiaki Takemoto, Ho Namkoong, Masatoshi Wakui, Hiromichi Matsushita, Naoki Hasegawa, Yasunori Sato & Mitsuru Murata. (2023) Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination. npj Vaccines 8:1.
Crossref
Crossref
Francis Mwimanzi, Hope R Lapointe, Peter K Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, Sneha Datwani, Laura Burns, Landon Young, Victor Leung, Siobhan Ennis, Chanson J Brumme, Julio S G Montaner, Winnie Dong, Natalie Prystajecky, Christopher F Lowe, Mari L DeMarco, Daniel T Holmes, Janet Simons, Masahiro Niikura, Marc G Romney, Zabrina L Brumme & Mark A Brockman. (2023) Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine. Open Forum Infectious Diseases 10:3.
Crossref
Crossref
Aleksandar Cvetkovic-Vega, Diego Urrunaga-Pastor, Percy Soto-Becerra, Luis E. Figueroa-Montes, Lizette Fernandez-Bolivar, Sergio Alvizuri-Pastor, Martin Oyanguren-Miranda, Ibeth Neyra-Vera, Elizabeth Carrillo-Ramos, Arturo Sagástegui, Roxana Contreras-Macazana, Diana Lecca-Rengifo, Nikolai Grande-Castro, Moises Apolaya-Segura & Jorge L. Maguina. (2023) Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm). Travel Medicine and Infectious Disease 52, pages 102514.
Crossref
Crossref
Wadha Alfouzan, Haya Altawalah, Ahmad AlSarraf, Walid Alali, Talal Al-Fadalah, Fahad Al-Ghimlas, Saud Alajmi, Mubarak Alajmi, Ebtehal AlRoomi, Ahlam Jeragh & Rita Dhar. (2023) Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait. Vaccines 11:2, pages 336.
Crossref
Crossref
Won Lee & Philip Kurien. (2023) Evaluation of a point of care lateral flow assay for antibody detection following SARS CoV-2 mRNA vaccine series. Journal of Immunological Methods 513, pages 113410.
Crossref
Crossref
Joo Guan Yeo, Kai Liang Teh, Wan Ni Chia, Yun Xin Book, Sook Fun Hoh, Xiaocong Gao, Lena Das, Jinyan Zhang, Nursyuhadah Sutamam, Su Li Poh, Amanda Jin Mei Lim, Shi Huan Tay, Katherine Nay Yaung, Xin Mei Ong, Jing Yao Leong, Lin-Fa Wang, Salvatore Albani & Thaschawee Arkachaisri. (2023) COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases. Rheumatology.
Crossref
Crossref
Francesca Lucca, Valentino Bezzerri, Elisa Danese, Debora Olioso, Denise Peserico, Christian Boni, Giulia Cucchetto, Martina Montagnana, Gloria Tridello, Ilaria Meneghelli, Mirco Ros, Giuseppe Lippi & Marco Cipolli. (2023) Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation. International Journal of Molecular Sciences 24:2, pages 908.
Crossref
Crossref
Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, Sayuri Mizushima, Kyoko Maeda, Yuko Fujimoto, Ryugo Sawada, Manabu Oda, Hiroshi Okuda, Mayumi Yamaki, Shin Hashiguchi, Ichiro Kawai, Izumi Kawaguchi, Noriyuki Masuda & Haruhiko Matsushita. (2023) Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers. Vaccine 41:2, pages 365-371.
Crossref
Crossref
Ricardo Javier Eliçabe, Matías Nicolás Distel, Brenda Lucila Jofré, Marianela Leporati, Juan Eduardo Silva, José Luis Arias, Carolina Virginia Gorlino, Samanta Celeste Funes, Marisol Velazquez, Patricia Vitale, Roberto Carlos Davicino & María Silvia Di Genaro. (2023) Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina. Vaccine 41:2, pages 476-485.
Crossref
Crossref
Julien Favresse, Constant Gillot, Jean‐Louis Bayart, Clara David, Germain Simon, Loris Wauthier, Mélanie Closset, Jean‐Michel Dogné & Jonathan Douxfils. (2022) Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster. Journal of Medical Virology 95:1.
Crossref
Crossref
Monica Basso, Nicole Pirola, Susanna Pascoli, Beatrice Bragato, Antonio Vinci, Marco Iannetta, Francesco Colombo, Nicholas Geremia, Luca Martignago, Maria Cristina Rossi, Ludovica Cipriani, Mario Giobbia, Pier Giorgio Scotton & Saverio Giuseppe Parisi. (2022) Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients. Vaccines 11:1, pages 82.
Crossref
Crossref
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, Ingo Fricke, Chinua Imarogbe & Karem H. Alzoubi. (2022) An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines. Vaccines 11:1, pages 51.
Crossref
Crossref
Annick Ocmant, Sandrine Roisin, Delphine Mathieu, Jonathan Brauner & Frédéric De Leener. (2022) Long-Term Dynamic of Anti-TrimericS and Anti-RBD Antibodies in Naive and COVID-19 Recovered mRNA-1273 Vaccine Recipients. Laboratory Medicine.
Crossref
Crossref
Min Li, Ruiwei Jiang, Enyun Wang, Dan Xiong, Tong Ou, Xiuming Zhang & Xiaowen Dou. (2022) Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world. BMC Infectious Diseases 22:1.
Crossref
Crossref
Chia Siang Kow, Dinesh Sangarran Ramachandram & Syed Shahzad Hasan. (2021) Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant. Journal of Neuroimmune Pharmacology 17:3-4, pages 425-426.
Crossref
Crossref
Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Khashayar Roshanzamir, Newsha Fallah, Greiciely Andre, Nikolai Petrovsky & Saghar Barati. (2022) Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial. Immunology 167:3, pages 340-353.
Crossref
Crossref
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya-Li Liang & Tar Choon Aw. (2022) 210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine. Vaccines 10:10, pages 1703.
Crossref
Crossref
Ariel E. Leon, Della Garelle, Airn Hartwig, Elizabeth A. Falendysz, Hon S. Ip, Julia S. Lankton, Tyler N. Tretten, Terry R. Spraker, Richard Bowen & Tonie E. Rocke. (2022) Immunogenicity, Safety, and Anti-Viral Efficacy of a Subunit SARS-CoV-2 Vaccine Candidate in Captive Black-Footed Ferrets (Mustela nigripes) and Their Susceptibility to Viral Challenge. Viruses 14:10, pages 2188.
Crossref
Crossref
Anthony Dobi, Arthur Dubernet, Mahary Lalarizo Rakoto, Anne-Laure Sandenon Seteyen, Damien Vagner, Grégorie Lebeau, Loïc Raffray & Philippe Gasque. (2022) Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels. Immunologic Research 70:5, pages 714-719.
Crossref
Crossref
Marlena Golec, Adam Konka, Martyna Fronczek, Joanna Zembala-John, Martyna Chrapiec, Karolina Wystyrk, Sławomir Kasperczyk, Zenon Brzoza & Rafał Jakub Bułdak. (2022) The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and Body Composition Parameters. Vaccines 10:10, pages 1638.
Crossref
Crossref
Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima, Kiyomi Hando, Khilola Saipova, Sayyora Akhmedova, Kanon Abe, Hirohito Imada, Md Razeen Ashraf Hussain, Serge Ouoba, Bunthen E, Ko Ko, Tomoyuki Akita, Shinichi Yamazaki, Michiya Yokozaki & Junko Tanaka. (2022) Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers. Scientific Reports 12:1.
Crossref
Crossref
Franz Mai, Johann Volzke, Emil C. Reisinger & Brigitte Müller-Hilke. (2022) Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition. Vaccines 10:9, pages 1563.
Crossref
Crossref
Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Azusa Kamikawa, Yumiko Kito, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari & Wataru Sugiura. (2022) SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study. Scientific Reports 12:1.
Crossref
Crossref
Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, Pauline Van Ngoc, Jan Yvan Jos Verbakel, An De Sutter, Stefan Heytens, Ann Van Den Bruel, Isabelle Desombere, Pierre Van Damme, Herman Goossens, Laetitia Buret, Els Duysburgh & Samuel Coenen. (2022) Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up. BMJ Open 12:9, pages e065897.
Crossref
Crossref
Ronglin Ma, Wei Xia, Rui Zhang, Guojia Fan, Libin Sun, Lei Qiu, Jinxin Cui, Songwen Ju, Pingping Wu, Jie Yang, Jian Xiong & Qiang Yu. (2022) Adjuvant-free cellulose nanofiber vaccine induces permanent humoral immune response in mouse. Nanotechnology 33:34, pages 345103.
Crossref
Crossref
Qian He, Qunying Mao, Jialu Zhang, Fan Gao, Yu Bai, Bopei Cui, Jianyang Liu, Chaoqiang An, Qian Wang, Xujia Yan, Jinghuan Yang, Lifang Song, Ziyang Song, Dong Liu, Yadi Yuan, Jing Sun, Jincun Zhao, Lianlian Bian, Xing Wu, Weijin Huang, Changgui Li, Junzhi Wang, Zhenglun Liang & Miao Xu. (2022) Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques. Frontiers in Immunology 13.
Crossref
Crossref
Pedro Ponce, Ricardo Peralta, Carla Felix, Carla Pinto, Bruno Pinto & João Fazendeiro Matos. (2022) Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age. International Journal of Environmental Research and Public Health 19:16, pages 10091.
Crossref
Crossref
Jing Ouyang, Silvere D. Zaongo, Vijay Harypursat, Xiaofang Li, Jean-Pierre Routy & Yaokai Chen. (2022) SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders. Frontiers in Public Health 10.
Crossref
Crossref
Raquel Rodriguez-Blanque, Juan Carlos Sánchez-García, Ángel Cobos-Vargas, Ana Aguilar Quesada, Jose A. Maldonado-Lobón, Mónica Olivares & Ruth Blanco-Rojo. (2022) Evaluation of the effect of Loigolactobacillus coryniformis K8 CECT 5711 consumption in health care workers exposed to COVID-19. Frontiers in Nutrition 9.
Crossref
Crossref
M. Gueguen, L. Khatchatourian, C. Lohéac, I. Dorval, M. Mercier, R. Le Calloch, K. Mahé, M.J. Rizcallah, P. Hutin, M.S. Fangous, N. Saidani & L. Le Clech. (2022) The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study. Infectious Diseases Now 52:5, pages 280-285.
Crossref
Crossref
Davide Firinu, Andrea Perra, Marcello Campagna, Roberto Littera, Giuseppe Fenu, Federico Meloni, Selene Cipri, Francesca Sedda, Maria Conti, Michela Miglianti, Giulia Costanzo, Marta Secci, Gianmario Usai, Mauro Giovanni Carta, Riccardo Cappai, Germano Orrù, Stefano Del Giacco, Ferdinando Coghe & Luchino Chessa. (2021) Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination. Clinical and Experimental Medicine 22:3, pages 477-485.
Crossref
Crossref
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Luigi Vimercati, Daniela Azzollini, Grazia Marinelli, Giovanni Coloccia, Fabio Piras, Giuseppe Barile, Vito Settanni, Antonio Mancini, Nicole De Leonardis, Grazia Garofoli, Giulia Palmieri, Ciro Gargiulo Isacco, Biagio Rapone, Arnaldo Scardapane, Luigi Curatoli, Nicola Quaranta, Mario Ribezzi, Maria Massaro, Megan Jones, Ioana Roxana Bordea, Gianluca Martino Tartaglia, Antonio Scarano, Felice Lorusso, Luigi Macchia, Angela Maria Vittoria Larocca, Sergey Khachatur Aityan, Silvio Tafuri, Pasquale Stefanizzi, Giovanni Migliore, Nicola Brienza, Gianna Dipalma, Gianfranco Favia & Francesco Inchingolo. (2022) Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast. International Journal of Molecular Sciences 23:15, pages 8485.
Crossref
Crossref
Chandrasekharan Rajalekshmi Dhanya, Aswathy Shailaja, Aarcha Shanmugha Mary, Sumodan Padikkala Kandiyil, Ambili Savithri, Vishnu Sasidharan Lathakumari, Jayakrishnan Therthala Veettil, Jiji Joseph Vandanamthadathil & Maya Madhavan. (2022) RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease. Pathogens 11:7, pages 800.
Crossref
Crossref
Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, Harsh Jogdand, Dugyala Raju, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Kumar Rai, Raches Ella, Priya Abraham, Sai Prasad & Krishna Ella. (2022) Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants. Scientific Reports 12:1.
Crossref
Crossref
Emilie Catry, Julien Favresse, Constant Gillot, Jean-Louis Bayart, Damien Frérotte, Michel Dumonceaux, Patrick Evrard, François Mullier, Jonathan Douxfils, François M. Carlier & Mélanie Closset. (2022) Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination. Viruses 14:7, pages 1470.
Crossref
Crossref
Masatoshi Matsunami, Tomo Suzuki, Shinnosuke Sugihara, Takumi Toishi, Kanako Nagaoka, Junko Fukuda, Mamiko Ohara, Yayoi Takanashi, Atsuhiko Ochi, Jun Yashima, Hiroshi Kuji & Kosei Matsue. (2022) Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study. Transplantation Proceedings 54:6, pages 1483-1488.
Crossref
Crossref
Jhonny Wilson Limachi Choque & Aleida Verduguez Orellana. (2022) Anticuerpos Anti SARS-CoV-2, Post-vacunación en Cochabamba, Bolivia. Gaceta Médica Boliviana 45:1, pages 29-35.
Crossref
Crossref
Narayan Prasad, Shyam Bihari Bansal, Brijesh Yadav, Neha Manhas, Deependra Yadav, Sonam Gautam, Ravishankar Kushwaha, Ankita Singh, Dharmendra Bhadauria, Monika Yachha, Manas Ranjan Behera & Anupama Kaul. (2022) Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center. Frontiers in Immunology 13.
Crossref
Crossref
Julien Favresse, Jean-Michel Dogné & Jonathan Douxfils. (2022) Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster. Clinical Chemistry and Laboratory Medicine (CCLM) 60:7, pages e153-e156.
Crossref
Crossref
Barbara Grüne, Jakob Grüne, Annelene Kossow & Christine Joisten. (2022) Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron). Vaccines 10:7, pages 1003.
Crossref
Crossref
Masaaki Takeuchi, Akina Esaki, Yukie Higa & Akemi Nakazono. (2022) Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?. PLOS ONE 17:6, pages e0263486.
Crossref
Crossref
Karen Cortés-Sarabia, Mayralina Gutiérrez-Torres, Escarlet Maleny Mendoza-Renteria, Marco Antonio Leyva-Vázquez, Amalia Vences-Velázquez, Daniel Hernández-Sotelo, Fredy Omar Beltrán-Anaya, Oscar Del Moral-Hernández & Berenice Illades-Aguiar. (2022) Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review. Vaccines 10:6, pages 909.
Crossref
Crossref
Zhe Ding, Tong Chen, Jiaming Lan & Gary Wong. (2022) Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants. Biosafety and Health 4:3, pages 154-160.
Crossref
Crossref
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu & Tar Choon Aw. (2022) Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore. Antibodies 11:2, pages 38.
Crossref
Crossref
Manca Ogrič, Polona Žigon, Eva Podovšovnik, Katja Lakota, Snezna Sodin-Semrl, Žiga Rotar & Saša Čučnik. (2022) Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals. Frontiers in Immunology 13.
Crossref
Crossref
Maja Stosic, Marija Milic, Milos Markovic, Ivana Kelic, Zoran Bukumiric, Marko Veljkovic, Darija Kisic Tepavcevic, Vladan Saponjic, Dragana Plavsa, Sofija Jovanovic & Verica Jovanovic. (2022) Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia. Vaccines 10:6, pages 838.
Crossref
Crossref
Maria Infantino, Mariangela Manfredi, Lorenzo Stacchini, Claudia Cosma, Valentina Grossi, Barbara Lari, Edda Russo, Amedeo Amedei, Maurizio Benucci, Francesca Veneziani, Patrizia Casprini, Cateno Mario Catalano, Giuseppe Cirrincione, Guglielmo Bonaccorsi & Adolfo Pompetti. (2022) The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers. Clinical Chemistry and Laboratory Medicine (CCLM) 60:6, pages 934-940.
Crossref
Crossref
Shugang Qin, Xiaoshan Tang, Yuting Chen, Kepan Chen, Na Fan, Wen Xiao, Qian Zheng, Guohong Li, Yuqing Teng, Min Wu & Xiangrong Song. (2022) mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Jia Wei, Koen B. Pouwels, Nicole Stoesser, Philippa C. Matthews, Ian Diamond, Ruth Studley, Emma Rourke, Duncan Cook, John I. Bell, John N. Newton, Jeremy Farrar, Alison Howarth, Brian D. Marsden, Sarah Hoosdally, E. Yvonne Jones, David I. Stuart, Derrick W. Crook, Tim E. A. Peto, A. Sarah Walker, David W. Eyre, Tina Thomas, Daniel Ayoubkhani, Russell Black, Antonio Felton, Megan Crees, Joel Jones, Lina Lloyd, Esther Sutherland, Emma Pritchard, Karina-Doris Vihta, George Doherty, James Kavanagh, Kevin K. Chau, Stephanie B. Hatch, Daniel Ebner, Lucas Martins Ferreira, Thomas Christott, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya, Sarah Cameron, Phoebe Tamblin-Hopper, Magda Wolna, Rachael Brown, Richard Cornall, Gavin Screaton, Katrina Lythgoe, David Bonsall, Tanya Golubchik, Helen Fryer, Stuart Cox, Kevin Paddon, Tim James, Thomas House, Julie Robotham, Paul Birrell, Helena Jordan, Tim Sheppard, Graham Athey, Dan Moody, Leigh Curry, Pamela Brereton, Ian Jarvis, Anna Godsmark, George Morris, Bobby Mallick, Phil Eeles, Jodie Hay, Harper VanSteenhouse, Jessica Lee, Sean White, Tim Evans, Lisa Bloemberg, Katie Allison, Anouska Pandya, Sophie Davis, David I. Conway, Margaret MacLeod & Chris Cunningham. (2022) Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nature Medicine 28:5, pages 1072-1082.
Crossref
Crossref
Ning Luan, Yunfei Wang, Han Cao, Kangyang Lin & Cunbao Liu. (2022) Comparison of immune responses induced by two or three doses of an alum‐adjuvanted inactivated SARS‐CoV‐2 vaccine in mice. Journal of Medical Virology 94:5, pages 2250-2258.
Crossref
Crossref
Derya Çağlayan, Ahmet F. Süner, Neslişah Şiyve, Irmak Güzel, Çağlar Irmak, Elif Işik, Özgür Appak, Muammer Çelik, Gamze Öztürk, Sema Alp Çavuş, Gül Ergör, Arzu Sayiner, Alp Ergör, Yücel Demiral & Bülent Kiliç. (2022) An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey. Journal of Medical Virology 94:5, pages 2212-2221.
Crossref
Crossref
Cleo Anastassopoulou, Dimitra Antoni, Yiannis Manoussopoulos, Panagiotis Stefanou, Sofia Argyropoulou, Georgia Vrioni & Athanasios Tsakris. (2022) Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods. PLOS ONE 17:4, pages e0266958.
Crossref
Crossref
Taysir Al Janabi & Maria Pino. (2022) To Boost or Not to Boost: Acceptability of a COVID-19 Booster Dose among Osteopathic Medical Students: A Cross-Sectional Study from a Medical School in New York. Epidemiologia 3:2, pages 218-228.
Crossref
Crossref
Rikei Kozakai, Kuniko Hoshi, Yoshihiko Izumi & Shinichiro Takahashi. (2022) Profound decline of antibody titers 6 months after BNT162b2 vaccination in healthy volunteers. Journal of Laboratory Medicine 46:2, pages 147-149.
Crossref
Crossref
Ting Zhao, Jiayan Shen, Youyang Zhu, Xiaofang Tian, Guangfen Wen, Yuanyuan Wei, Bonan Xu, Chenyang Fu, Zhaohu Xie, Yujiang Xi, Zhenmin Li, Jiangyun Peng, Yang Wu, Xiaohu Tang, Chunping Wan, Lei Pan, Zhaofu Li & Dongdong Qin. (2022) Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series. Frontiers in Public Health 10.
Crossref
Crossref
Takeshi Mochizuki, Takaki Hori, Koichiro Yano, Katsunori Ikari & Ken Okazaki. (2022) Factors Associated with Change in SARS-CoV-2 Antibody Titers from Three to Six Months after the Administration of the BNT162b2 mRNA COVID-19 Vaccine among Healthcare Workers in Japan: A Prospective Study. Internal Medicine 61:8, pages 1139-1143.
Crossref
Crossref
Sina Hosseinian, Kathleen Powers, Milind Vasudev, Anton M. Palma, Rafael de Assis, Aarti Jain, Peter Horvath, Paramveer S. Birring, Rana Andary, Connie Au, Brandon Chin, Ghali Khalil, Jenny Ventura, Madeleine K. Luu, Cesar Figueroa, Joshua M. Obiero, Emily Silzel, Rie Nakajima, William Thomas Gombrich, Algis Jasinskas, Frank Zaldivar, Sebastian Schubl, Philip L. Felgner & Saahir Khan. (2022) Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray. Frontiers in Immunology 13.
Crossref
Crossref
Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura & Katsushi Tokunaga. (2022) An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine. Vaccines 10:4, pages 563.
Crossref
Crossref
F.K. Cheng. (2022) Debate on mandatory COVID-19 vaccination. Ethics, Medicine and Public Health 21, pages 100761.
Crossref
Crossref
Hui Xie, Xiaojing Wen, Juan Li, Weixin Chen, Meng Chen, Lichi Zhang, Min Lv, Shanshan Zhou, Shuang Bai, Wei Zhao, Jian Wang & Jiang Wu. (2022) Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization. International Journal of Infectious Diseases 117, pages 97-102.
Crossref
Crossref
Gang Zeng, Qianhui Wu, Hongxing Pan, Minjie Li, Juan Yang, Lin Wang, Zhiwei Wu, Deyu Jiang, Xiaowei Deng, Kai Chu, Wen Zheng, Lei Wang, Wanying Lu, Bihua Han, Yuliang Zhao, Fengcai Zhu, Hongjie Yu & Weidong Yin. (2022) Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. The Lancet Infectious Diseases 22:4, pages 483-495.
Crossref
Crossref
Diana Rodríguez-Espinosa, José Jesús Broseta, José Luis Bedini, Néstor Rodríguez & Francisco Maduell. (2022) Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients. Clinical Kidney Journal 15:4, pages 818-819.
Crossref
Crossref
José Jesús Broseta, Diana Rodríguez-Espinosa, Elena Cuadrado, Néstor Rodríguez, José Luis Bedini & Francisco Maduell. (2022) Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients. Vaccines 10:4, pages 522.
Crossref
Crossref
Krzysztof Lukaszuk, Amira Podolak, Paulina Malinowska, Jakub Lukaszuk & Grzegorz Jakiel. (2022) Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study. Vaccines 10:4, pages 521.
Crossref
Crossref
Juan Francisco Gutiérrez-Bautista, Antonio Sampedro, Esther Gómez-Vicente, Javier Rodríguez-Granger, Juan Antonio Reguera, Fernando Cobo, Francisco Ruiz-Cabello & Miguel Ángel López-Nevot. (2022) HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine. Vaccines 10:3, pages 402.
Crossref
Crossref
Narayan Prasad, Brijesh Yadav, Mantabya Singh, Sonam Gautam, Dharmendra Bhadauria, Manas Patel, Ravi Kushwaha, Deependra Yadav, Ankita Singh, Monika Yachha, Manas Behera & Anupama Kaul. (2022) Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients. Vaccines 10:3, pages 385.
Crossref
Crossref
Maria Elena Romero-Ibarguengoitia, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Arnulfo González-Cantú, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Laura Patricia Montelongo-Cruz, Gerardo Francisco Del Rio-Parra, Mauricio René Garza-Herrera, Jessica Andrea Leal-Meléndez & Miguel Ángel Sanz-Sánchez. (2022) Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel. PLOS ONE 17:3, pages e0263942.
Crossref
Crossref
Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Yaniv Lustig, Carmit Cohen, Galia Rahav, Keren Asraf, Sharon Amit, Hanaa Jaber, Ital Nemet, Limor Kliker, Erez Bar-Haim, Ella Mendelson, Ram Doolman, Carmit Rubin, Gili Regev-Yochay & Yitshak Kreiss. (2022) Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience. The Journal of Infectious Diseases 225:5, pages 785-792.
Crossref
Crossref
Caroline M. Hsu, Daniel E. Weiner, Harold J. Manley, Gideon N. Aweh, Vladimir Ladik, Jill Frament, Dana Miskulin, Christos Argyropoulos, Kenneth Abreo, Andrew Chin, Reginald Gladish, Loay Salman, Doug Johnson & Eduardo K. Lacson. (2022) Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. Clinical Journal of the American Society of Nephrology 17:3, pages 403-413.
Crossref
Crossref
Yuxin Chen, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Jie Pan, Ming Li, Yawen Wan, Minxin Mao, Yali Xiong, Xiaomin Yan, Yue Yang, Rui Huang, Chao Wu & Han Shen. (2022) Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine. Clinical Microbiology and Infection 28:3, pages 410-418.
Crossref
Crossref
Brigitte Müller-Hilke, Franz Mai, Michael Müller, Johann Volzke & Emil C. Reisinger. (2022) Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. Vaccines 10:2, pages 322.
Crossref
Crossref
Rossana Elena Chahla, Rodrigo Hernán Tomas-Grau, Silvia Inés Cazorla, Diego Ploper, Esteban Vera Pingitore, Mónica Aguilar López, Patricia Aznar, María Elena Alcorta, Eva María del Mar Vélez, Agustín Stagnetto, César Luís Ávila, Carolina Maldonado-Galdeano, Sergio Benjamín Socias, Dar Heinze, Silvia Adriana Navarro, Conrado Juan Llapur, Dardo Costa, Isolina Flores, Alexis Edelstein, Shreyas Kowdle, Claudia Perandones, Benhur Lee, Gabriela Apfelbaum, Raúl Mostoslavsky, Gustavo Mostoslavsky, Gabriela Perdigón & Rosana Nieves Chehín. (2022) Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina. The Lancet Regional Health - Americas 6, pages 100123.
Crossref
Crossref
Marie C Béné, Marcelo de Carvalho Bittencourt & Patrice Chevallier. (2022) Post-SARS-CoV-2 vaccination specific antibody decrease : Let's get the half-full glass perspective. Journal of Infection 84:1, pages 94-118.
Crossref
Crossref
Alejo Erice, David Varillas-Delgado & Cristina Caballero. (2022) Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults. Clinical Microbiology and Infection 28:1, pages 139.e1-139.e4.
Crossref
Crossref
Xaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, Soo Aleman, Daniel J Sheward, Leo Hanke, Marcus Ahl, Linnea Vikström, Mattias Forsell, Jonathan M Coquet, Gerald McInerney, Joakim Dillner, Gordana Bogdanovic, Ben Murrell, Jan Albert, Chris Wallace & Gunilla B Karlsson Hedestam. (2022) Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates. Clinical & Translational Immunology 11:3.
Crossref
Crossref
Seri Jeong, Nuri Lee, Su-Kyung Lee, Eun-Jung Cho, Jungwon Hyun, Min-Jeong Park, Wonkeun Song, Eun-Ju Jung, Heungjeong Woo, Yu-Bin Seo, Jin-Ju Park & Hyun-Soo Kim. (2021) Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer. Diagnostics 12:1, pages 85.
Crossref
Crossref
Hari Ram Choudhary, Debaprasad Parai, Girish Chandra Dash, Jaya Singh Kshatri, Narayan Mishra, Prasanta Kumar Choudhary, Dipti Pattnaik, Kumudini Panigrahi, Susmita Behera, Nihar Ranjan Sahoo, Sreeparna Podder, Adyasha Mishra, Sunil Kumar Raghav, Sanjeeb Kumar Mishra, Subrat Kumar Pradhan, Subrat Kumar Sahoo, Matrujyoti Pattnaik, Usha Kiran Rout, Rashmi Ranjan Nanda, Nityananda Mondal, Srikanta Kanungo, Subrata Kumar Palo, Debdutta Bhattacharya & Sanghamitra Pati. (2021) Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines. Frontiers in Medicine 8.
Crossref
Crossref
Cláudia Lemos, Sofia Ferreira, Cláudio Gouveia, Érica Mendonça, Ana Marta Mota, Mariana Rodrigues, José Alves, Susana Chaves, Graça Andrade & José J Nóbrega. (2021) Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Healthcare Workers After Vaccine Administration in an Intensive Care Unit. Cureus.
Crossref
Crossref
Blanka Wolszczak-Biedrzycka, Anna Bieńkowska & Justyna Dorf. (2021) Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection. Vaccines 9:12, pages 1508.
Crossref
Crossref
Davide Firinu, Andrea Perra, Marcello Campagna, Roberto Littera, Federico Meloni, Francesca Sedda, Maria Conti, Giulia Costanzo, Monica Erbi, Gianmario Usai, Carlotta Locci, Mauro Giovanni Carta, Riccardo Cappai, Germano Orrù, Stefano Del Giacco, Ferdinando Coghe & Luchino Chessa. (2021) Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study. Vaccines 9:12, pages 1478.
Crossref
Crossref
Tudor Rares Olariu, Sorin Ursoniu, Iosif Marincu & Maria Alina Lupu. (2021) Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study. Medicina 57:12, pages 1330.
Crossref
Crossref
José Jesús Broseta, Diana Rodríguez-Espinosa, José Luis Bedini, Néstor Rodríguez & Francisco Maduell. (2021) Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients. Nephrology Dialysis Transplantation 36:12, pages 2340-2341.
Crossref
Crossref
Eva Schrezenmeier, Hector Rincon-Arevalo, Ana-Luisa Stefanski, Alexander Potekhin, Henriette Staub-Hohenbleicher, Mira Choi, Friederike Bachmann, Vanessa Proβ, Charlotte Hammett, Hubert Schrezenmeier, Carolin Ludwig, Bernd Jahrsdörfer, Andreia C. Lino, Kai-Uwe Eckardt, Katja Kotsch, Thomas Dörner, Klemens Budde, Arne Sattler & Fabian Halleck. (2021) B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. Journal of the American Society of Nephrology 32:12, pages 3027-3033.
Crossref
Crossref
Sita Awasthi, James J. Knox, Angela Desmond, Mohamad-Gabriel Alameh, Brian T. Gaudette, John M. Lubinski, Alexis Naughton, Lauren M. Hook, Kevin P. Egan, Ying K. Tam, Norbert Pardi, David Allman, Eline T. Luning Prak, Michael P. Cancro, Drew Weissman, Gary H. Cohen & Harvey M. Friedman. (2021) Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models. Journal of Clinical Investigation 131:23.
Crossref
Crossref
Davide Ferrari, Nicola Clementi, Elena Criscuolo, Alessandro Ambrosi, Francesca Corea, Chiara Di Resta, Rossella Tomaiuolo, Nicasio Mancini, Massimo Locatelli, Mario Plebani & Giuseppe Banfi. (2021) Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Vaccines 9:11, pages 1357.
Crossref
Crossref
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luís Alberto Brêda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed & Roberto Badaró. (2021) The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines 9:11, pages 1345.
Crossref
Crossref
Lea Hsu, Barbara Grüne, Michael Buess, Christine Joisten, Jan Klobucnik, Johannes Nießen, David Patten, Anna Wolff, Gerhard A. Wiesmüller, Annelene Kossow & Julia Hurraß. (2021) COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne). Vaccines 9:11, pages 1267.
Crossref
Crossref
Marie Tré-Hardy, Roberto Cupaiolo, Alain Wilmet, Thomas Antoine-Moussiaux, Andrea Della Vecchia, Alexandra Horeanga, Emmanuelle Papleux, Marc Vekemans, Ingrid Beukinga & Laurent Blairon. (2021) Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. Journal of Infection 83:5, pages 559-564.
Crossref
Crossref
Chin-Shern Lau, Soon Kieng Phua, Ya-Li Liang, Helen May-Lin Oh & Tar-Choon Aw. (2021) Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine. Vaccines 9:11, pages 1241.
Crossref
Crossref
Rami Alqassieh, Aiman Suleiman, Sami Abu-Halaweh, Abeer Santarisi, Omar Shatnawi, Lara Shdaifat, Amjed Tarifi, Mohammad Al-Tamimi, Abdel-Ellah Al-Shudifat, Heba Alsmadi, Ahmed Al Sharqawi, Hadeel Alnawaiseh, Yara Anasweh, Farah Abo Domaidah, Haneen Abu Jaber, Mohammad Rashid Al-Zarir & Isam Bsisu. (2021) Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers. Vaccines 9:11, pages 1223.
Crossref
Crossref
Claudius Speer, Matthias Schaier, Christian Nusshag, Maximilian Töllner, Mirabel Buylaert, Florian Kälble, Paula Reichel, Julia Grenz, Caner Süsal, Martin Zeier, Paul Schnitzler, Christian Morath, Katrin Klein & Louise Benning. (2021) Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks. Vaccines 9:10, pages 1130.
Crossref
Crossref
Flaminia Campo, Aldo Venuti, Fulvia Pimpinelli, Elva Abril, Giovanni Blandino, Laura Conti, Armando De Virgilio, Federico De Marco, Vincenzo Di Noia, Enea Gino Di Domenico, Simona Di Martino, Fabrizio Ensoli, Diana Giannarelli, Chiara Mandoj, Francesco Mazzola, Silvia Moretto, Gerardo Petruzzi, Fabrizio Petrone, Barbara Pichi, Martina Pontone, Antonello Vidiri, Branka Vujovic, Giulia Piaggio, Eleonora Sperandio, Valentina Rosati, Francesco Cognetti, Aldo Morrone, Gennaro Ciliberto & Raul Pellini. (2021) Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers. Vaccines 9:10, pages 1125.
Crossref
Crossref
Junichiro NISHI. (2021) Effectiveness and Safety of COVID-19 VaccineCOVID-19ワクチンの有効性と安全性. TRENDS IN THE SCIENCES 26:10, pages 10_18-10_25.
Crossref
Crossref
Jonathan Douxfils, Constant Gillot, François Mullier & Julien Favresse. (2021) Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ. Journal of Infection 83:4, pages e4-e5.
Crossref
Crossref
Jean-Louis Bayart, Jonathan Douxfils, Constant Gillot, Clara David, François Mullier, Marc Elsen, Christine Eucher, Sandrine Van Eeckhoudt, Tatiana Roy, Vincent Gerin, Grégoire Wieers, Christine Laurent, Mélanie Closset, Jean-Michel Dogné & Julien Favresse. (2021) Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines 9:10, pages 1092.
Crossref
Crossref
Daniel Grupel, Sivan Gazit, Licita Schreiber, Varda Nadler, Tamar Wolf, Rachel Lazar, Lia Supino-Rosin, Galit Perez, Asaf Peretz, Amir Ben Tov, Miri Mizrahi-Reuveni, Gabriel Chodick & Tal Patalon. (2021) Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination. Vaccine 39:38, pages 5337-5340.
Crossref
Crossref
Jonathan Douxfils, Constant Gillot, Émilie De Gottal, Stéphanie Vandervinne, Jean-Louis Bayart, Jean-Michel Dogné & Julien Favresse. (2021) Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature. Vaccines 9:8, pages 907.
Crossref
Crossref
Julien Favresse, Constant Gillot, Laura Di Chiaro, Christine Eucher, Marc Elsen, Sandrine Van Eeckhoudt, Clara David, Laure Morimont, Jean-Michel Dogné & Jonathan Douxfils. (2021) Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses 13:7, pages 1364.
Crossref
Crossref
Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, Ferdinando Nicoletti, Francisco Javier Turrubiates-Hernández, Katia Mangano & José Francisco Muñoz-Valle. (2021) A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies. International Journal of Immunopathology and Pharmacology 35, pages 205873842110501.
Crossref
Crossref